here - Australian College of Veterinary Scientists
here - Australian College of Veterinary Scientists
here - Australian College of Veterinary Scientists
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Intradermal Testing (IDT) in Horses:<br />
The UK Perspective<br />
Janet Littlewood<br />
Horses with a history <strong>of</strong> recurrent pruritus and /or urticaria represent the largest<br />
proportion <strong>of</strong> equine dermatology referral cases in the author's practice. Referred<br />
cases usually have a history <strong>of</strong> recurrent problems <strong>of</strong> at least 2 months duration.<br />
Ideally an elimination diet is undertaken before referral – although the almost<br />
complete absence <strong>of</strong> well-defined cases <strong>of</strong> adverse cutaneous food reaction in horses<br />
makes it a rare diagnosis, and so this is not considered essential, either prior to or<br />
after referral, although it is advised. Clients are <strong>of</strong>ten reluctant to limit their horses to<br />
strict, narrow elimination diets, particularly if they want to continue to work the<br />
horse. History and clinical examination are undertaken to rule out other possible<br />
causes <strong>of</strong> urticaria and pruritus, and if the signs are consistent with hypersensitivity,<br />
intradermal testing is undertaken. The author requests that horses be <strong>of</strong>f<br />
antihistamines for a minimum <strong>of</strong> 2 weeks and have received no steroids for a month<br />
(ideally), although withdrawal <strong>of</strong> low dose alternate day steroids may not need to be<br />
for this period. Food additives, particularly aloe vera extract, should also be<br />
withdrawn – this advice is given on the basis <strong>of</strong> negative intradermal test results<br />
being obtained in a horse currently receiving aloe vera, with positive results obtained<br />
at retesting 3 weeks after withdrawal.<br />
Horses are sedated for intradermal testing, with detomidine hydrochloride (0.06-<br />
0.12mg/kg) and butorphanol 0.075-0.15mg/kg) intravenously. An area on the lateral<br />
aspect <strong>of</strong> the shoulder is clipped with a number 40 blade and injection sites marked<br />
with a permanent marker pen at 2 cm intervals. Allergens for testing are obtained<br />
from Greer Laboratories Inc., North Carolina, USA with additional forage mites<br />
supplied by Artuvetrin Biologicals nv, Lelystad, Netherlands. In the past allergens<br />
have also been supplied by Stallervet, France. The selection <strong>of</strong> allergens used in<br />
intradermal testing in dogs in the UK was originally based on advice obtained from<br />
colleagues in human allergy medicine and using information from publications and<br />
texts. Over the years the author has changed and refined the test kit, in conjunction<br />
with colleagues and in the light <strong>of</strong> frequency <strong>of</strong> negative and positive reactions. In<br />
fact, apart from the Culicoides antigen, which is restricted for testing <strong>of</strong> horses, the<br />
author currently uses the same allergens in dogs and horses. Allergens supplied from<br />
Greer are stored in concentrated form and diluted to testing strength, w<strong>here</strong>as the<br />
European allergens are supplied at testing strength. The testing strengths used are<br />
selected on the basis <strong>of</strong> advice from the allergen companies and from published data.<br />
The restrictions on experimentation in the UK mean that very little work has been<br />
done on optimising <strong>of</strong> allergen concentrations, apart from work done on Culicoides<br />
ACVSC Proceedings Dermatology Chapter Science Week 2005 31